Just last week I asked a South Florida urologist about
Lupron for the superelderly. If a 90 year old spikes a PSA greater than his age, he recommends a trial on Lupron, and if the patient tolerates it well, keeps him on it for the rest of his life. The thinking is to prevent bone breaks, which can be catastrophic in nonogenarians, and painful end of life from mPCa. Makes sense to me.
Age 60 at dx 7/2017 biopsy G8 (4+4), 5/13 cores
RARP 8/2017 (Patel), pT3a N0 M0, 30% tumor; EPE+, SV-
PSA 1/2016, 2.9; 4/2017, 7.2; 9/2017 (post-RARP), 0.13; 10/2017, <0.05, 1/9/2018, 0.09, 2/23/2018, 0.08.
Eligard started 3/2/2018. SRT 72Gy, 40 fractions, finished 5/8/2018
PSA 8/2018, <0.02
Caution: I’m not an MD and don’t know what I’m talking about
Post Edited (Saipan Paradise) : 12/4/2018 12:58:04 PM (GMT-7)